The influence of immunosuppression switching in liver function in adult hepatic transplantation

Hepato-Gastroenterology

Volumn 58, Issue 106, 2011, Pages 532-535

  Gómez, Luis Miguel Marin ^a,b   Segurota, Carmelo Loinaz ^a,c   González, Enrique Moreno ^a   Elola Olaso, Almudena Moreno ^a   Arrillaga, Ignacio González Pinto ^a,d   Diaz, Juan Carlos Meneu ^a   De Usera, Manuel Abradelo ^a   Sanz, Ramón Gómez ^a   Romero, Carlos Jiménez ^a   Ureña, Miguel Ángel Garcia ^a,e   Ruiz, Vicente Vega ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL DEL HENARES   (Spain)

Author keywords

Calcineurins antagonists; Immunosuppression; Liver transplantation; Outcome

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOSPORIN A; FRESH FROZEN PLASMA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; TRIACYLGLYCEROL;

ACUTE LIVER DISEASE; ADULT; ARTICLE; CHOLESTATIC CIRRHOSIS; CHOLESTEROL BLOOD LEVEL; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE CONCENTRATE; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; LIVER DISEASE; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC CIRRHOSIS; MICROEMULSION; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NOSE FEEDING; PARENCHYMATOUS CIRRHOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AZATHIOPRINE; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 79958128590     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Emre S, Genyk Y, Schluger LK, et al: Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int 2000; 13:73-78. (Pubitemid 30417387)
2. Busuttil RW, Holt CD: Tacrolimus is superior to cyclosporine in liver transplantation. Transplant Proc 1998; 30:2174-2178. (Pubitemid 28399468)
3. Fung, JJ, Todo S, Jain A, et al: Conversion from cyclosporine to FK506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990; 22:6-12. (Pubitemid 20112741)
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al: Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993; 55:807-813. (Pubitemid 23122053)
5. Rull R, Vidal O, Momblan D, et al: Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl 2003; 9:389-393. (Pubitemid 36443053)
6. Strasberg SM, Howard TK, Molmenti EP, et al: Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20:829-838. (Pubitemid 24296488)
7. Deschenes M, Forbes C, Tchervenkov J, et al: Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation. Liver Transpl Surg 1999; 5:357-361.
8. Dousset B, Conti F, Cherruau B: Is acute rejection deleterious to long-term liver allograft function?. J Hepatol 1998; 29:660-668. (Pubitemid 28484957)
9. González-Pinto I, Alonso O, Loinaz C, et al: Usefulness of the switch to tacrolimus in liver transplantation. Transplant Proc 1999; 31:2425-2426. (Pubitemid 29433986)
10. Abouljoud MS, Kumar MS, Graymar MS, et al: Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant 2002; 16:168-172. (Pubitemid 34746392)